8.2 Safety evaluation and long-term risk management Chronic peptide therapy raises safety considerations that differ in some respects from those of small molecules ( Experience with GLP-1 receptor agonists underscores the importance of contextualizing safety signals rather than interpreting them in isolation
The breadth of the development program reflects confidence in the Phase 2 results and suggests that retatrutide, if approved, will be positioned as a comprehensive metabolic therapy rather than simply a weight loss drug
While semaglutide has shown many benefits, such as improving blood sugar levels and aiding in weight loss, it is not free of side effects
Mounjaro (tirzepatide) is in the same class of medications as Ozempic (semaglutide)
A clinician then removes the needle, applies light pressure and disposes of the sharp safely in a sharps bin
Mastrocola R, Aragno M, Alloatti G, Collino M, Penna C, Pagliaro P